Venetoclax Plus Hypomethylating Agent for the Salvage Treatment of Myeloid Malignancies Relapsing after Hematopoietic Stem Cell Transplantation: A Multicenter Retrospective Study on Behalf of the Zhejiang Cooperative Group for Blood and Marrow Transplantation

被引：0

作者：

Gao, Fei ^{[1
]}

Luo, Yi ^{[1
]}

Yu, Jian ^{[1
]}

Fu, Huarui ^{[1
]}

Lai, Xiaoyu ^{[1
]}

Liu, Lizhen ^{[1
]}

Ye, Baodong ^{[2
]}

Lan, Jianping ^{[3
]}

Song, Xiaolu ^{[3
]}

Lu, Ying ^{[4
]}

Chen, Lieguang ^{[4
]}

Chen, Yi ^{[5
]}

Yu, Kang ^{[5
]}

Huang, He ^{[1
]}

Shi, Jimin ^{[1
]}

Zhao, Yanmin ^{[1
]}

机构：

[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou, Peoples R China

[2] Zhejiang Chinese Med Univ, Dept Hematol, Affiliated Hosp 1, Hangzhou, Peoples R China

[3] Zhejiang Prov Peoples Hosp, Dept Hematol & Hematopoiet Stem Cell Transplant C, Hangzhou, Peoples R China

[4] Ningbo Univ, Dept Hematol, Med Sch, Yinzhou Hosp, Ningbo, Peoples R China

[5] Wenzhou Med Univ, Dept Hematol, Affiliated Hosp 1, Wenzhou, Peoples R China

来源：

关键词：

D O I：

10.1182/blood-2021-146364

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1825

引用

页码：1825 / +

页数：4